LTA and breast carcinoma: It is noteworthy that elevated TGFβ signaling and downregulation of miR-200c were also demonstrated in trastuzumab-resistant breast cancer cells while increased miR-200c or the blockade of TNFβ signaling increased trastuzumab sensitivity and inhibited invasiveness of breast cancer cells [128].